NEWARK, N.Y., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) announced today the addition of Janie Goddard as Director of the Company. Chairman Bradford Whitmore said, “We are pleased to welcome Janie to our Board of Directors and look forward to leveraging her extensive

NEWARK, N.Y., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ended December 31, 2022 before the market opens on Thursday, March 2, 2023. We are reporting our quarterly results later than our customary reporting practice

NEWARK, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Ultralife Corporation (“Ultralife” or the “Company”) (NASDAQ: ULBI) has appointed Michael E. Manna as the Company’s President & CEO and as a member of the Board of Directors effective immediately to replace Michael D.

NEWARK, N.Y., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported an operating loss of $0.6 million and adjusted EBITDA of $1.3 million on revenue of $33.2 million for the third quarter ended September 30, 2022. For the third quarter of 2021, the Company reported an

NEWARK, N.Y., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has been awarded a purchase order valued at approximately $5.5 million to supply its vehicle communications systems to a global prime defense contractor for the U.S. Army.

NEWARK, N.Y., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2022, before the market opens on Thursday, October 27, 2022. Ultralife’s Management will also host an investor conference call and

NEWARK, N.Y., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received a contract valued at approximately $7.5 million to supply its integrated system of A-320 amplifiers and A-320HVA radio vehicle mounts to a major international defense contractor for an ongoing

NEWARK, N.Y., July 28, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating income of $0.8 million and Adjusted EBITDA of $2.2 million on revenue of $32.1 million for the second quarter ended June 30, 2022. For the second quarter of 2021, the Company reported operating

NEWARK, N.Y., July 26, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has been awarded a purchase order valued at approximately $4.6 million to supply its Vehicle Amplifier-Adaptors (“VAA”) to a global prime defense contractor. Ultralife’s VAA platform provides the soldier with an

NEWARK, N.Y., July 14, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2022, before the market opens on Thursday, July 28, 2022. Ultralife’s Management will also host an investor conference call and simultaneous